Carl Zeiss Meditec AG
CZMWYOTCHealthcare● Active
$29.58
$-0.56(-1.85%)
Market Cap$2.6B
P/E Ratio—
52W High$72.57
52W Low$26.65
Carl Zeiss Meditec AG (CZMWY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CZMWY · earnings · updated Jun 10, 2026
Latest Earnings
Q2 FY2026Report Date: May 12, 2026EPS Actual
$1.05
Revenue
$0.74B
Est. $0.60B · +22.7%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 12, 2026
After Market Close
▲ Beat Revenue
CZMWY reports quarterly as a OTC-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Next earnings date not yet announced.
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q4 FY2026 | Dec 10, 2026 | — | — | — | — | — | — |
| — Q2 FY2026 | May 12, 2026 | — | $1.05 | — | $0.74B | $0.60B | +22.7% |
| — Q2 FY2026 | May 12, 2026 | — | $0.38 | — | $1.16B | — | — |
| ▼ Q2 FY2026 | May 11, 2026 | $1.22 | $0.20 | -84.0% | $1.16B | $0.93B | +24.8% |
| ◌ Q1 FY2026 | Feb 10, 2026 | $1.22 | — | — | — | $0.92B | — |
| — Q3 FY2025 | Aug 7, 2025 | — | $0.33 | — | $0.55B | $0.60B | -8.2% |
| — Q2 FY2025 | May 13, 2025 | — | $0.57 | — | $0.61B | $0.59B | +3.9% |
| — Q1 FY2025 | Feb 7, 2025 | — | $0.19 | — | $0.51B | $0.56B | -8.7% |
Q4 FY2026
Dec 10, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 12, 2026
EPS Actual
$1.05
EPS Est.
—
EPS Surpr.
—
Revenue
$0.74B
Q2 FY2026
May 12, 2026
EPS Actual
$0.38
EPS Est.
—
EPS Surpr.
—
Revenue
$1.16B
Q2 FY2026
May 11, 2026Miss
EPS Actual
$0.20
EPS Est.
$1.22
EPS Surpr.
-84.0%
Revenue
$1.16B
Q1 FY2026
Feb 10, 2026
EPS Actual
—
EPS Est.
$1.22
EPS Surpr.
—
Revenue
—
Q3 FY2025
Aug 7, 2025
EPS Actual
$0.33
EPS Est.
—
EPS Surpr.
—
Revenue
$0.55B
Q2 FY2025
May 13, 2025
EPS Actual
$0.57
EPS Est.
—
EPS Surpr.
—
Revenue
$0.61B
Q1 FY2025
Feb 7, 2025
EPS Actual
$0.19
EPS Est.
—
EPS Surpr.
—
Revenue
$0.51B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $1.18 | $1.20 | $1.22 | 1 |
| Q2 FY2026 | $1.18 | $1.20 | $1.22 | 1 |
| Q1 FY2026 | $1.04 | $1.06 | $1.08 | 1 |
| Q4 FY2025 | $1.02 | $1.04 | $1.05 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q3 FY2026 | $0.9B | $0.9B | $0.9B | 2 |
| Q2 FY2026 | $0.9B | $0.9B | $0.9B | 1 |
| Q1 FY2026 | $0.8B | $0.8B | $0.8B | 2 |
| Q4 FY2025 | $0.8B | $0.8B | $0.8B | 2 |
| Q3 FY2025 | $0.5B | $0.5B | $0.5B | 7 |
| Q2 FY2025 | $0.5B | $0.5B | $0.5B | 7 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2026 | May 12, 2026 | — | $30.67 | $33.59 | +9.52% |
| — Q2 FY2026 | May 12, 2026 | — | $30.67 | $33.59 | +9.52% |
| ▼ Q2 FY2026 | May 11, 2026 | -84.0% | $30.27 | $30.67 | +1.32% |
| — Q3 FY2025 | Aug 7, 2025 | — | $55.38 | $50.24 | -9.28% |
| — Q2 FY2025 | May 13, 2025 | — | $69.33 | $71.73 | +3.46% |
| — Q1 FY2025 | Feb 7, 2025 | — | $61.23 | $58.68 | -4.16% |
| — Q3 FY2024 | Sep 30, 2024 | — | $78.69 | $79.08 | +0.50% |
| — Q3 FY2024 | Aug 6, 2024 | — | $66.43 | $69.83 | +5.12% |
Q2 FY2026+9.52%
Report Date
May 12, 2026
EPS Beat/Miss
—
Price Before
$30.67
Price After
$33.59
Q2 FY2026+9.52%
Report Date
May 12, 2026
EPS Beat/Miss
—
Price Before
$30.67
Price After
$33.59
Q2 FY2026+1.32%
Report Date
May 11, 2026
EPS Beat/Miss
-84.0%
Price Before
$30.27
Price After
$30.67
Q3 FY2025-9.28%
Report Date
Aug 7, 2025
EPS Beat/Miss
—
Price Before
$55.38
Price After
$50.24
Q2 FY2025+3.46%
Report Date
May 13, 2025
EPS Beat/Miss
—
Price Before
$69.33
Price After
$71.73
Q1 FY2025-4.16%
Report Date
Feb 7, 2025
EPS Beat/Miss
—
Price Before
$61.23
Price After
$58.68
Q3 FY2024+0.50%
Report Date
Sep 30, 2024
EPS Beat/Miss
—
Price Before
$78.69
Price After
$79.08
Q3 FY2024+5.12%
Report Date
Aug 6, 2024
EPS Beat/Miss
—
Price Before
$66.43
Price After
$69.83
Avg Miss Reaction+1.32%
Beat Rate0 / 8 quarters
Largest Move+9.52% (Q2 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CZMWY ends December
Carl Zeiss Meditec AG (CZMWY) most recently reported earnings on May 12, 2026 for Q2 FY2026, posting EPS of $1.05 (in line with the analyst consensus of —).
Each quarter, investors track CZMWY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CZMWY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CZMWY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CZMWY earnings · 4 questionsCarl Zeiss Meditec AG's next earnings report is expected around TBD. CZMWY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CZMWY historically reports after market close (AMC).
CZMWY earnings datewhen is CZMWY earningsCZMWY next earnings datewhen does CZMWY report earningsCZMWY earnings calendar
▸ Source: FMP · Carl Zeiss Meditec AG SEC filings · US GAAP · Carl Zeiss Meditec AG SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026